AAAAAA
Results:
1-16
|
Results: 16
Authors:
Ladetto, M
Sametti, S
Astolfi, M
Corradini, P
Ricca, I
Drandi, D
Pileri, A
Tarella, C
Citation: M. Ladetto et al., Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting, LEUK LYMPH, 40(5-6), 2001, pp. 679-682
Authors:
Tarella, C
Cuttica, A
Caracciolo, D
Zallio, F
Ricca, I
Bergui, L
Gavarotti, P
Marinone, C
Pagano, M
Rossi, G
de Crescenzo, A
Salomone, A
Ladetto, M
Boccadoro, M
Pileri, A
Citation: C. Tarella et al., High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments, ANN HEMATOL, 80, 2001, pp. B123-B126
Authors:
Tarella, C
Zallio, F
Caracciolo, D
Cuttica, A
Corradini, P
Gavarotti, P
Ladetto, M
Podio, V
Sargiotto, A
Rossi, G
Gianni, AM
Pileri, A
Citation: C. Tarella et al., High-dose mitoxantrone plus melphalan (MITO/L-PAM) as conditioning regimensupported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity, LEUKEMIA, 15(2), 2001, pp. 256-263
Authors:
Guglielmi, C
Martelli, M
Federico, M
Zinzani, PL
Vitolo, U
Bellesi, G
Santini, G
Tarella, C
Zallio, F
Pregno, P
Di Renzo, N
Resegotti, L
Citation: C. Guglielmi et al., Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas, HAEMATOLOG, 86(9), 2001, pp. 941-950
Authors:
Ladetto, M
Sametti, S
Donovan, JW
Ferrero, D
Astolfi, M
Mitterer, M
Ricca, I
Drandi, D
Corradini, P
Coser, P
Pileri, A
Gribben, JC
Tarella, C
Citation: M. Ladetto et al., A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients, EXP HEMATOL, 29(2), 2001, pp. 183-193
Authors:
Cortelazzo, S
Rambaldi, A
Rossi, A
Oldani, E
Ghielmin, M
Benedetti, F
Tarella, C
Zaglio, F
Vitolo, U
Di Nicola, M
Pogliani, E
Cavalli, F
Gianni, AM
Barbui, T
Citation: S. Cortelazzo et al., Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma, BR J HAEM, 114(2), 2001, pp. 333-341
Authors:
Ladetto, M
Bergui, L
Ricca, I
Campana, S
Pileri, A
Tarella, C
Citation: M. Ladetto et al., Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients, MED ONCOL, 17(3), 2000, pp. 203-210
Authors:
Tarella, C
Caracciolo, D
Corradini, P
Zallio, F
Ladetto, M
Cuttica, A
Rossi, G
Novero, D
Gavarotti, P
Pileri, A
Citation: C. Tarella et al., Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft, LEUKEMIA, 14(4), 2000, pp. 740-747
Authors:
Tarella, C
Caracciolo, D
Gavarotti, P
Argentino, C
Zallio, F
Corradini, P
Novero, D
Magnani, C
Pileri, A
Citation: C. Tarella et al., Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft, BONE MAR TR, 26(11), 2000, pp. 1185-1191
Authors:
Magni, M
Di Nicola, M
Devizzi, L
Matteucci, P
Lombardi, F
Gandola, L
Ravagnani, F
Giardini, R
Dastoli, G
Tarella, C
Pileri, A
Bonadonna, G
Gianni, AM
Citation: M. Magni et al., Successful in vivo purging of CD34-containing peripheral blood harvests inmantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion, BLOOD, 96(3), 2000, pp. 864-869
Authors:
Tarella, C
Zallio, F
Caracciolo, D
Cherasco, C
Bondesan, P
Gavarotti, P
Corradini, P
Tassi, V
Pileri, A
Citation: C. Tarella et al., Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients, STEM CELLS, 17(1), 1999, pp. 55-61
Authors:
Tarella, C
Corradini, P
Astolfi, M
Bondesan, P
Caracciolo, D
Cherasco, C
Ladetto, M
Giaretta, F
Ricca, I
Vitolo, U
Pileri, A
Ferrero, D
Citation: C. Tarella et al., Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions, LEUKEMIA, 13(9), 1999, pp. 1456-1462
Authors:
Corradini, P
Ladetto, M
Pileri, A
Tarella, C
Citation: P. Corradini et al., Clinical relevance of minimal residual disease monitoring in non-Hodgkin'slymphomas: a critical reappraisal of molecular strategies, LEUKEMIA, 13(11), 1999, pp. 1691-1695
Authors:
Corradini, P
Voena, C
Tarella, C
Astolfi, M
Ladetto, M
Palumbo, A
Van Lint, MT
Bacigalupo, A
Santoro, A
Musso, M
Majolino, I
Boccadoro, M
Pileri, A
Citation: P. Corradini et al., Molecular and clinical remissions in multiple myeloma: Role of autologous and allogeneic transplantation of hematopoietic cells, J CL ONCOL, 17(1), 1999, pp. 208-215
Authors:
Boccadoro, M
Tarella, C
Palumbo, A
Argentino, C
Triolo, S
Dominietto, A
Callea, V
Lauta, VM
Molica, S
Musto, P
Marmont, F
Gianni, AM
Pileri, A
Citation: M. Boccadoro et al., An analysis of which subgroups of multiple myeloma patients, divided according to beta(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy, HAEMATOLOG, 84(10), 1999, pp. 905-910
Authors:
Palumbo, A
Triolo, S
Argentino, C
Bringhen, S
Dominietto, A
Rus, C
Omede, P
Tarella, C
Pileri, A
Boccadoro, M
Citation: A. Palumbo et al., Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients, BLOOD, 94(4), 1999, pp. 1248-1253
Risultati:
1-16
|